Onco-Innovations Announces Non-Brokered Private Placement

Onco-Innovations Limited, listed on CBOE, has announced its intention to execute a non-brokered private placement, aimed at raising approximately CAD$5 million. This offering includes 6,764,069 units, priced at CAD$0.7392 each. The units consist of one common share and one share purchase warrant. Each warrant permits purchasing an additional share at CAD$0.90 within three years. The closing date is expected around July 10, 2026, pending regulatory approval.

The funds from this offering will support the ONC010 program's development, focus on manufacturing, preclinical activities, and enhance the SynoGraph™ platform. The placement, available to Canadian residents excluding Quebec, will follow the Listed Issuer Financing Exemption, allowing investors to trade units without a holding period.